The health ministry has decided to set up an autonomous drug control authority on the lines of the US Food and Drugs Administration, but with a mandate going far beyond the latter.
The United States appears to be a relatively hospitable place for embryonic stem cell research, especially compared to Canada and some nations in Europe where governments not only refuse financial support for human cloning to produce stem cells, they outlaw the practice.
The editor-in-chief of the New England Journal of Medicine accused three of the largest drug companies of ‘making a mockery‘ of efforts to create transparency in clinical trials, adding that could lead some important medical publications to avoid publishing their studies.
With a closely divided House poised to vote today on whether to expand federal funding of human embryonic stem cell research, opponents are offering fence-sitters what they say is an embryo-friendly alternative: a bill that would foster the use of stem cells from umbilical cords discarded after birth.
The U.S. government is dangling a big carrot — and some wheat and corn — to encourage manufacturers to make more products from biobased materials.
How does Genentech do it? The biotech company focuses on science — not marketing, acquisitions, or patents
U.S. prices for brand-name drugs on average rose at 2.5 times the rate of inflation last year, while generic drug prices remained flat, according to a study released on Tuesday by the nation’s largest lobby for the elderly.
There is no difference between meat and milk from cloned livestock and those foods obtained from conventionally bred cattle, according to a study released today.
As part of an agency-wide initiative to speed development of new medical products through the science of pharmacogenomics, the FDA has issued a final guidance regarding pharmacogenomic data submissions.